ABVC BioPharma, Inc.
ABVC
$2.41
-$0.12-4.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.77% | -168.02% | -467.25% | 158.08% | 58.10% |
| Total Depreciation and Amortization | 18.81% | -29.06% | -36.48% | 68.52% | -6.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.68% | 693.83% | 130.45% | -339.19% | -35.53% |
| Change in Net Operating Assets | 56.76% | -1,795.85% | 91.25% | -446.86% | -63.53% |
| Cash from Operations | 85.09% | -65.65% | -9.36% | -919.93% | 128.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -91.26% | -- | -- | -- | 108.93% |
| Cash from Investing | -91.26% | -- | -- | -- | 108.93% |
| Total Debt Issued | 1,566.67% | -- | -- | 202.39% | -175.75% |
| Total Debt Repaid | -353.04% | -152.90% | 83.45% | 1.17% | -- |
| Issuance of Common Stock | -35.35% | 395.21% | 439.58% | -90.11% | 488.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -200.00% | -- | -- | 100.00% |
| Cash from Financing | -41.24% | 349.46% | -26.26% | 814.37% | -110.15% |
| Foreign Exchange rate Adjustments | 202.37% | -844.12% | 11.48% | 79.41% | 162.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -170.20% | 404.03% | -210.97% | 246.49% | -67.66% |